Αποτελέσματα Αναζήτησης
PAXLOVID is a medicine for mild-to-moderate COVID-19 in high-risk patients under EUA. Learn about its benefits, risks, side effects, interactions, and how to take it.
PAXLOVID is a medicine for mild-to-moderate COVID-19 in high-risk children and adults. Learn about its risks, benefits, side effects, interactions, and how to take it.
If it’s COVID, PAXLOVID. PAXLOVID is a prescription treatment for mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. Learn how to get PAXLOVID.
27 Ιαν 2022 · Paxlovid should be given as soon as possible after a diagnosis of COVID-19 has been made and within 5 days of the start of symptoms. For more information about using Paxlovid, see the package leaflet or contact your doctor or pharmacist.
4 Μαΐ 2022 · Patient information for Paxlovid. Updated 4 May 2022. Paxlovid is an antiviral medicine that stops SARS-CoV-2 (the virus that causes COVID-19) from multiplying in the body. This keeps...
Fact Sheet for Patients, Parents, and Caregivers: Emergency Use Authorization (EUA) of PAXLOVID™ for Coronavirus Disease 2019 (COVID-19)
See risks & benefits. Explore frequently asked questions about PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) for COVID-19.
